These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 27448505)

  • 41. Preparation and Characterization of a Monoclonal Antibody Against the Core Protein VP7 of the 25th Serotype of Bluetongue Virus.
    Wu X; Liu Q; He J; Zang M; Wang H; Li Y; Tang L
    Monoclon Antib Immunodiagn Immunother; 2015 Apr; 34(2):116-21. PubMed ID: 25897610
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Multiple genome segments determine virulence of bluetongue virus serotype 8.
    Janowicz A; Caporale M; Shaw A; Gulletta S; Di Gialleonardo L; Ratinier M; Palmarini M
    J Virol; 2015 May; 89(10):5238-49. PubMed ID: 25822026
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bluetongue virus with mutated genome segment 10 to differentiate infected from vaccinated animals: a genetic DIVA approach.
    van Rijn PA; van de Water SG; van Gennip HG
    Vaccine; 2013 Oct; 31(44):5005-8. PubMed ID: 24021311
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Marker vaccine potential of foot-and-mouth disease virus with large deletion in the non-structural proteins 3A and 3B.
    Biswal JK; Subramaniam S; Ranjan R; Sharma GK; Misri J; Pattnaik B
    Biologicals; 2015 Nov; 43(6):504-11. PubMed ID: 26260689
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The significance of the structural characteristics of the agent for the problems of immunization against blue tongue].
    Müller H
    Tierarztl Prax; 1991 Dec; 19(6):591-5. PubMed ID: 1665600
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression of the major core structural protein (VP7) of bluetongue virus, by a recombinant capripox virus, provides partial protection of sheep against a virulent heterotypic bluetongue virus challenge.
    Wade-Evans AM; Romero CH; Mellor P; Takamatsu H; Anderson J; Thevasagayam J; Fleming MJ; Mertens PP; Black DN
    Virology; 1996 Jun; 220(1):227-31. PubMed ID: 8659119
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recombinant vaccines against bluetongue virus.
    Calvo-Pinilla E; Castillo-Olivares J; Jabbar T; Ortego J; de la Poza F; Marín-López A
    Virus Res; 2014 Mar; 182():78-86. PubMed ID: 24287057
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Expression of the 3a and 3d fusion protein of hepatitis A virus in prokaryotic cell and antigenicity analysis].
    Cheng H; Zhou Y; Guo Y; Bi S
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Sep; 16(3):215-8. PubMed ID: 12665922
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Localization of the single-stranded RNA-binding domains of bluetongue virus nonstructural protein NS2.
    Fillmore GC; Lin H; Li JK
    J Virol; 2002 Jan; 76(2):499-506. PubMed ID: 11752140
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of cross-protection of bluetongue virus serotype 4 with other serotypes in sheep.
    Zulu GB; Venter EH
    J S Afr Vet Assoc; 2014 Oct; 85(1):1041. PubMed ID: 25686101
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recombinant canarypox virus vaccine co-expressing genes encoding the VP2 and VP5 outer capsid proteins of bluetongue virus induces high level protection in sheep.
    Boone JD; Balasuriya UB; Karaca K; Audonnet JC; Yao J; He L; Nordgren R; Monaco F; Savini G; Gardner IA; Maclachlan NJ
    Vaccine; 2007 Jan; 25(4):672-8. PubMed ID: 17059856
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expression of the major epitope regions of 2C integrated with the 3AB non-structural protein of foot-and-mouth disease virus and its potential for differentiating infected from vaccinated animals.
    Lu Z; Zhang X; Fu Y; Cao Y; Tian M; Sun P; Li D; Liu Z; Xie Q
    J Virol Methods; 2010 Dec; 170(1-2):128-33. PubMed ID: 20863858
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Vaccines against bluetongue in Europe.
    Savini G; MacLachlan NJ; Sanchez-Vizcaino JM; Zientara S
    Comp Immunol Microbiol Infect Dis; 2008 Mar; 31(2-3):101-20. PubMed ID: 17765305
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Subclinical bluetongue virus infection in domestic ruminants in Taiwan.
    Lee F; Ting LJ; Jong MH; Chang WM; Wang FI
    Vet Microbiol; 2010 May; 142(3-4):225-31. PubMed ID: 19900768
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An experimental subunit vaccine based on Bluetongue virus 4 VP2 protein fused to an antigen-presenting cells single chain antibody elicits cellular and humoral immune responses in cattle, guinea pigs and IFNAR(-/-) mice.
    Legisa DM; Perez Aguirreburualde MS; Gonzalez FN; Marin-Lopez A; Ruiz V; Wigdorovitz A; Martinez-Escribano JA; Ortego J; Dus Santos MJ
    Vaccine; 2015 May; 33(22):2614-9. PubMed ID: 25858859
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High efficiency prokaryotic expression and purification of a portion of the hepatitis C core protein and analysis of the immune response to recombinant protein in BALB/c mice.
    Hitomi Y; McDonnell WM; Baker JR; Askari FK
    Viral Immunol; 1995; 8(2):109-19. PubMed ID: 8825296
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Monoclonal antibodies raised against bluetongue virus detect viral antigen in infected tissues using an indirect immunoperoxidase method.
    Cherrington JM; Ghalib HW; Davis WC; Osburn BI
    Prog Clin Biol Res; 1985; 178():505-10. PubMed ID: 2989893
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The NS3 proteins of global strains of bluetongue virus evolve into regional topotypes through negative (purifying) selection.
    Balasuriya UB; Nadler SA; Wilson WC; Pritchard LI; Smythe AB; Savini G; Monaco F; De Santis P; Zhang N; Tabachnick WJ; Maclachlan NJ
    Vet Microbiol; 2008 Jan; 126(1-3):91-100. PubMed ID: 17706379
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rapid detection and quantitation of Bluetongue virus (BTV) using a Molecular Beacon fluorescent probe assay.
    Orrù G; Ferrando ML; Meloni M; Liciardi M; Savini G; De Santis P
    J Virol Methods; 2006 Oct; 137(1):34-42. PubMed ID: 16876884
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High level expression and purification of recombinant 3ABC non-structural protein of foot-and-mouth disease virus using SUMO fusion system.
    Zia MA; Shah MS; Shafqat Ali Khan R; Farooq U; Shafi J; Habib M
    Protein Expr Purif; 2022 Mar; 191():106025. PubMed ID: 34826607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.